Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Transformed Recurrent Non-Hodgkin Lymphoma

Known as: Transformed Recurrent Non-Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Transformed Recurrent, Transformed Lymphoma 
The reemergence of non-Hodgkin lymphoma transformed after a period of remission.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Ibrutinib has generated remarkable responses in patients with chronic lymphocytic leukemia (CLL), including those with an… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • figure 4
2014
2014
The effect of core excitation in the elastic scattering and breakup of a two-body halo nucleus on a stable target nucleus is… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
2014
2014
The optimum follow-up of patients with transformed indolent lymphoma (TrIL) is not well defined. We sought to determine the… Expand
  • table 1
  • table 2
  • table 2
Highly Cited
2013
Highly Cited
2013
Metal-organic frameworks (MOFs) have been arousing a great interest owing to their unique physicochemical properties. In this… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Highly Cited
2011
Highly Cited
2011
BACKGROUND Lenalidomide is an immunomodulatory agent with antitumor activity in B-cell malignancies. This phase II trial aimed to… Expand
2011
2011
Transformed lymphoma (TL) represents a heterogeneous group of lymphomas with an aggressive course and poor prognosis. We assessed… Expand
Highly Cited
2009
Highly Cited
2009
BACKGROUND We previously correlated non-Hodgkin's lymphoma (NHL) histology with (18)fluoro-2-deoxyglucose-positron emission… Expand
Review
2002
Review
2002
  • F. Hagemeister
  • Cancer Chemotherapy and Pharmacology
  • 2002
  • Corpus ID: 25774613
Abstract. Treatment of aggressive lymphoma in relapse is difficult. Patients who initially present with these diseases often know… Expand
2001
2001
A synergistic interaction of Bcl-2 and c-Myc plays a role in lymphomagenesis in mice and in some patients as well. Progression of… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
1980
1980
The Marek's Disease virus‐transformed, non‐producer, lymphoma cell line, MDCC‐RP1, was selected by sequential transplantation to… Expand